Zura Bio Ltd. Files 8-K

TL;DR

Zura Bio Ltd. filed its 8-K on March 4, 2024, updating its corporate and financial reporting.

AI Summary

Zura Bio Ltd. (formerly JATT Acquisition Corp.) filed an 8-K on March 4, 2024, reporting on its business and financial status. The company, incorporated in the Cayman Islands, is in the biological products sector and has its principal executive offices in Henderson, Nevada. This filing serves as a current report under the Securities Exchange Act of 1934.

Why It Matters

This 8-K filing provides an update on Zura Bio Ltd.'s corporate status and regulatory compliance, which is important for investors tracking the company's public disclosures.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

• Zura Bio Ltd. (company) — Registrant
• JATT Acquisition Corp. (company) — Former company name
• 0001104659-24-030193 (filing_id) — Accession Number
• March 4, 2024 (date) — Date of Report
• Cayman Islands (jurisdiction) — State of incorporation
• Henderson, NV (location) — Address of principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar
• $11.50 — Ordinary Share at an exercise price of $11.50 per share ZURAW The Nasdaq Stock Ma

Filing Documents

• tm247615d1_8k.htm (8-K) — 30KB
• tm247615d1_ex99-1.htm (EX-99.1) — 12KB
• image_009.jpg (GRAPHIC) — 2KB
• image_011.jpg (GRAPHIC) — 2KB
• 0001104659-24-030193.txt ( ) — 268KB
• zura-20240304.xsd (EX-101.SCH) — 3KB
• zura-20240304_def.xml (EX-101.DEF) — 26KB
• zura-20240304_lab.xml (EX-101.LAB) — 36KB
• zura-20240304_pre.xml (EX-101.PRE) — 25KB
• tm247615d1_8k_htm.xml (XML) — 5KB

01

Item 7.01. Regulation FD Disclosure. On March 4, 2024, Zura Bio Limited issued the press release attached hereto as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 4, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 4, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR